1-2 of 2
B. Eichhorst
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies

D. Thomalla, L. Beckmann, C. Grimm, M. Oliverio, L. Meder, C.D. Herling, P. Nieper, T. Feldmann, O. Merkel, E. Lorsy, A. da Palma Guerreiro, J. von Jan, I. Kisis, E. Wasserburger, J. Claasen, E. Faitschuk-Meyer, J. Altmüller, P. Nürnberg, T.-P. Yang, M. Lienhard, R. Herwig, K.-A. Kreuzer, C.P. Pallasch, R. Büttner, S.C. Schäfer, J. Hartley, H. Abken, M. Peifer, H. Kashkar, G. Knittel, B. Eichhorst, R.T. Ullrich, M. Herling, H.C. Reinhardt, M. Hallek, M.R. Schweiger, L.P. Frenzel
Journal: Blood
Blood (2022) 140 (20): 2113–2126.
https://doi.org/10.1182/blood.2021014304
Published: 2022
Includes: Supplemental data
Journal Articles

Consolidation with Alemtuzumab Improves Progression-Free Survival in Patients with Chronic Lymphocytic Leukemia (CLL) in First Remission - Long-Term Follow-Up of a Randomized Phase III Trial of the German CLL Study Group (GCLLSG).

C. Schweighofer, M. Ritgen, B. Eichhorst, R. Busch, M. Kneba, M. Hallek, Clemens Wendtner, the German CLL Study Group
Journal: Blood
Blood (2006) 108 (11): 33.
https://doi.org/10.1182/blood.V108.11.33.33
Published: 2006